SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 6 4 2021
medline: 27 7 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

Pain is the leading cause of unplanned emergency department visits and readmissions after ureteroscopy, making postoperative analgesic stewardship a priority given the current opioid epidemic. We conducted a double-blinded, randomized controlled trial, with noninferiority design, comparing nonsteroidal anti-inflammatory drugs to opiates for postoperative pain control in patients undergoing ureteroscopy for urolithiasis. Patients were randomized and blinded to either oxycodone (5 mg) or ketorolac (10 mg), taken as needed, with 3 nonblinded oxycodone rescue pills for breakthrough pain. Primary study outcome was visual analogue scale pain score on postoperative days 1-5. Secondary outcomes included medication utilization, side effects, and Ureteral Stent Symptom Questionnaire scores. A total of 81 patients were included (43 oxycodone, 38 ketorolac). The 2 groups had comparable patient, stone, and perioperative characteristics. No differences were found in postoperative pain scores, study medication or rescue pill usage, or side effects. Higher maximum pain scores on days 1-5 (p <0.05) and higher questionnaire score (28.1 vs 21.7, p=0.045) correlated with analgesic usage, irrespective of treatment group. Patients receiving ketorolac reported significantly fewer days confined to bed (mean±SD 1.3±1.3 vs 2.3±2.6, p=0.02). There was no difference in unscheduled postoperative physician encounters. This is the first double-blinded randomized controlled trial comparing nonsteroidal anti-inflammatory drugs and opiates post-ureteroscopy, and demonstrates noninferiority of nonsteroidal anti-inflammatory drugs in pain control with similar efficacy, safety profile, physician contact and notably, earlier convalescence compared to the opioid group. This provides strong evidence against routine opioid use post-ureteroscopy, justifying continued investigation into reducing postoperative opiate prescriptions.

Identifiants

pubmed: 33819072
doi: 10.1097/JU.0000000000001772
doi:

Substances chimiques

Analgesics, Opioid 0
Anti-Inflammatory Agents, Non-Steroidal 0
Oxycodone CD35PMG570
Ketorolac YZI5105V0L

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-381

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Donald Fedrigon (D)

Department of Urology, Emory University, Atlanta, Georgia.

Anna Faris (A)

Department of Urology, University of Michigan, Ann Arbor, Michigan.

Naveen Kachroo (N)

Department of Urology, Henry Ford Health System, Detroit, Michigan.

Rajat Jain (R)

Department of Urology, University of Rochester, Rochester, New York.

Marlie Elia (M)

Department of Surgery, University of Washington, Seattle, Washington.

Lamont Wilkins (L)

Brady Urological Institute, Johns Hopkins, Baltimore, Maryland.

Jianbo Li (J)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.

Smita De (S)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.

Mark Noble (M)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.

Manoj Monga (M)

Department of Urology, University of California San Diego, San Diego, California.

Sri Sivalingam (S)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH